Written by Keen Meds  ·  Reviewed by Licensed Clinical Providers  ·  March 1, 2026

Key Insight: Clinical hypogonadism diagnosis requires total testosterone below 300 ng/dL on two separate morning fasting blood draws combined with consistent symptoms -- a single borderline measurement is insufficient for diagnosis or treatment initiation per all major clinical guidelines.

Getting a testosterone blood test and receiving a results report can be both informative and confusing. The report typically shows multiple values with reference ranges, flagging some as low or high, without context for what each marker means, how they relate to each other, or what a borderline number actually implies. Understanding what each measurement represents, why the timing of your blood draw matters, and what questions to ask your provider puts you in a much better position to have an informed conversation about your results. This guide explains every marker in a complete testosterone panel, why two morning fasting tests are required for diagnosis, what "borderline" means in practice, and what next steps look like based on your results.

Why Timing Matters: The Morning Fasting Requirement

Testosterone is not constant throughout the day. It follows a pronounced diurnal rhythm in young and middle-aged men: levels peak in the early morning, typically between 7 and 10 AM, and decline progressively through the afternoon and evening.

The magnitude of this diurnal variation is clinically significant. Afternoon testosterone levels can be 15 to 30% lower than morning values in the same man on the same day. If you have your blood drawn at 2 PM, your result may reflect a value that is genuinely 100 to 150 ng/dL lower than your morning peak. This means a man with a morning total testosterone of 350 ng/dL might show 230 ng/dL on an afternoon draw -- appearing definitively deficient when he is actually borderline.

This is why all major clinical guidelines specify that testosterone testing for hypogonadism evaluation should be done in the morning, typically before 10 AM, in a fasting state. Fasting matters because both food consumption and circulating insulin can acutely affect testosterone levels and other hormonal markers.

The diurnal rhythm becomes less pronounced with age -- men over 60 show smaller morning-to-afternoon variation -- but morning fasting testing remains the standard for consistent, comparable measurements across the population.

The Two-Test Requirement

A single testosterone measurement, even if low, is not sufficient to diagnose hypogonadism. Day-to-day variation in testosterone levels is real: measurements taken on two different mornings from the same individual can vary by 15 to 20% or more due to normal biological variation, sleep quality the previous night, recent physical activity, stress, and laboratory variability.

All major clinical guidelines -- including the Endocrine Society (2018), the European Andrology Association (2020), the British Society for Sexual Medicine (2023), and the International Consultation on Sexual Medicine (2024) -- specify that diagnosis requires two separate measurements below the threshold, both obtained under morning fasting conditions.

If your first testosterone test is low, a second test on a different day is the appropriate next step before treatment decisions are made. This is not a delay tactic -- it is a diagnostic standard that prevents treatment based on a single anomalous measurement.

Every Marker on Your Testosterone Panel, Explained

Total Testosterone
The sum of all testosterone in blood: tightly SHBG-bound (biologically inactive), loosely albumin-bound (bioavailable), and free (unbound, most directly active). Normal range is laboratory-dependent, but most clinical guidelines set the hypogonadism threshold at less than 300 ng/dL. Values between 300 and 400 ng/dL are considered borderline and require interpretation in the context of symptoms, free testosterone, and SHBG.

Free Testosterone
The unbound fraction of testosterone, representing approximately 2% of total testosterone. Most clinically potent because it diffuses freely into cells without needing to dissociate from a carrier protein. Can be calculated from total testosterone + SHBG + albumin using the Vermeulen formula, or measured directly by equilibrium dialysis (more accurate but less commonly available). Most important when total testosterone is borderline and SHBG is elevated.

SHBG (Sex Hormone-Binding Globulin)
The protein that tightly binds approximately 60% of circulating testosterone and renders it biologically inactive. Elevated SHBG reduces free and bioavailable testosterone, meaning effective testosterone availability can be low even when total testosterone is within the reference range. SHBG rises with age, liver disease, hyperthyroidism, and some medications. Low SHBG (common in obese men with insulin resistance) means more of a given total testosterone is bioavailable.

LH (Luteinizing Hormone)
Released by the anterior pituitary in response to hypothalamic GnRH. Stimulates Leydig cells in the testes to produce testosterone. LH level in the context of low testosterone indicates where the problem is. High LH with low testosterone = primary hypogonadism (testicular failure). Low or inappropriately normal LH with low testosterone = secondary hypogonadism (hypothalamic or pituitary dysfunction). This distinction guides treatment decisions.

FSH (Follicle-Stimulating Hormone)
Also released by the anterior pituitary. Stimulates Sertoli cells in the testes, which support spermatogenesis. Low FSH on TRT is expected (exogenous testosterone suppresses the HPG axis). Elevated FSH with low testosterone in an untreated man indicates primary testicular failure. Very low FSH alongside low testosterone suggests pituitary or hypothalamic disease.

Hematocrit
The proportion of red blood cells in a volume of blood, expressed as a percentage. Normal adult male range is approximately 38 to 50%. Baseline hematocrit before starting TRT is essential for monitoring, since TRT raises red blood cell production through erythropoietin stimulation. The clinical action threshold on TRT is 54% -- above this level, dose adjustment or other intervention is indicated. Monitoring hematocrit at 3 months and then annually is standard of care.

PSA (Prostate-Specific Antigen)
A protein produced by prostate tissue. PSA measurement before starting TRT is standard in men over 40 to establish a baseline for subsequent monitoring. TRT does not cause prostate cancer, but it can accelerate growth of existing undetected prostate cancer. A rapidly rising PSA on TRT warrants urological evaluation. A baseline PSA allows meaningful comparison over time.

Complete Blood Count (CBC)
Includes red blood cell count, hemoglobin, white blood cell count, and platelet count. The red blood cell and hemoglobin values provide additional context for hematocrit monitoring on TRT. A baseline CBC before starting TRT is appropriate clinical practice.

What "Borderline" Testosterone Means

A result between 300 and 400 ng/dL is often called borderline low. This range is clinically ambiguous: technically above the standard 300 ng/dL threshold, but lower than the range associated with optimal androgen-sensitive tissue function.

The clinical significance of a borderline total testosterone depends heavily on free testosterone and SHBG. If SHBG is elevated and free testosterone is below normal, a total testosterone of 350 ng/dL may represent genuine functional deficiency. If SHBG is low and free testosterone is normal, the same total testosterone is less concerning.

Symptoms matter at the borderline level. A man with total testosterone of 330 ng/dL and prominent symptoms of hypogonadism -- including reduced libido, fatigue, mood changes, and reduced muscle mass -- presents a different clinical picture than a man with the same level and no symptoms. The Endocrine Society acknowledges that the symptomatic context is a required part of the diagnostic equation: no number alone is sufficient.

Questions to Ask Your Provider After Your Testosterone Test

Given what you now know, these are the appropriate questions to bring to your clinical evaluation:

Were both measurements obtained in the morning in a fasting state? If not, you may need to repeat testing under the correct conditions.

What is my free testosterone, and has my SHBG been measured? These values are particularly important if your total testosterone is borderline or if your symptoms and total testosterone do not seem to align.

What is my LH level, and what does it suggest about where in the axis the problem originates? This determines which treatment approaches are appropriate.

What is my baseline hematocrit? This establishes the reference point for monitoring on therapy.

What is my PSA? Baseline PSA in men over 40 is standard before starting TRT.

Frequently Asked Questions

Can I get an accurate testosterone reading without fasting?
Non-fasting testing is common in clinical practice for convenience, but it reduces precision. Food and insulin fluctuations can modestly affect testosterone levels, and the day-to-day variation that morning fasting testing is designed to minimize becomes harder to control without consistent pre-test conditions. For a diagnostic test that will inform a treatment decision, morning fasting is the appropriate standard.

What if my lab's "normal range" is different from the 300 ng/dL threshold?
Laboratory reference ranges are set by each lab based on their specific assay and reference population. Some labs use 264 ng/dL as the lower limit of normal; others use 300 ng/dL or 280 ng/dL. The Endocrine Society's clinical guideline uses less than 300 ng/dL as the diagnostic threshold for hypogonadism. Your provider should interpret your result in the context of the specific lab's reference range and current clinical guidelines, not just whether the computer flagged it as "low."

What if one test is low and the second test is normal?
Inconsistent results across two tests is not unusual and reflects real biological variability. In this situation, clinical judgment guides next steps -- typically a third measurement, or a closer look at the conditions under which each test was taken (time of day, fasting status, recent illness, sleep quality). The diagnosis requires consistency, not a single outlier.

How quickly should I get my second testosterone test after the first?
Most clinical guidelines recommend confirming a low testosterone result with a second test within weeks to a few months, depending on the clinical context and urgency of the patient's symptoms. There is no benefit to waiting many months. If your first test is below 300 ng/dL and you have symptoms, scheduling the second test promptly is appropriate.


What This Means for Your Treatment Decisions

Understanding your testosterone panel equips you to be an active participant in your own diagnostic evaluation. Two confirmed low morning fasting measurements plus consistent symptoms are the foundation for a hypogonadism diagnosis. SHBG and free testosterone complete the picture. LH tells you where in the axis the problem lies. All of this informs what treatment is appropriate for your specific situation.

Keen Meds connects you with licensed clinical providers for a telehealth evaluation and lab review. If your testosterone is clinically low, you may qualify for Testosterone Spray Rx.

Learn about the Keen Testosterone Spray Program →